Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer : The European Organisation for Research and Treatment of Cancer Chronotherapy group
- Publication date
- 1 January 2006
- Publisher
- 'American Society of Clinical Oncology (ASCO)'